Processa Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Details Narrative)

Organization and Summary of Significant Accounting Policies (Details Narrative) - USD ($)						3 Months Ended						9 Months Ended
	Jul. 31, 2024	May 31, 2024	May 21, 2024	Jan. 30, 2024	Jan. 22, 2024	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Jan. 21, 2024	Dec. 31, 2023
OrganizationLineItems [Line Items]
Reverse stock split					1-for-20 reverse stock split
Common stock, par value					$ 0.0001	$ 0.0001						$ 0.0001			$ 0.0001
Common stock shares issued					1,291,000	3,271,944						3,271,944		24,706,474	1,291,000
Common stock shares outstanding					1,286,000	3,266,944						3,266,944		24,606,474	1,286,000
Common stock shares authorized					100,000,000	100,000,000						100,000,000			100,000,000
Accumulated deficit						$ 84,490,491						$ 84,490,491			$ 75,369,081
Net loss						3,384,703	$ 3,010,326	$ 2,726,381	$ 2,081,951	$ 2,612,565	$ 4,022,073	9,121,410	$ 8,716,589
Net cash for operating activities from continuing operations												8,997,321	5,939,478
Net proceeds from sale of common stock				$ 6,300,000								7,213,721	$ 6,352,077
Cash and cash equivalents						$ 2,891,464						2,891,464			$ 4,706,197
ATM Offering [Member]
OrganizationLineItems [Line Items]
Shares issued	374,190
Net proceeds from sale of common stock	$ 931,000											$ 931,000
Registration Statement [Member] \| Maximum [Member]
OrganizationLineItems [Line Items]
Maximum value to be sold		$ 50,000,000
Purchase Agreement [Member]
OrganizationLineItems [Line Items]
Shares issued				476,000								476,000
Net proceeds from sale of common stock												$ 6,300,000
Purchase Agreement [Member] \| Warrant [Member]
OrganizationLineItems [Line Items]
Warrants to purchase shares				1,555,555		1,555,555						1,555,555
Purchase Agreement [Member] \| Pre-Funded Warrants [Member]
OrganizationLineItems [Line Items]
Warrants to purchase shares				1,079,555		1,079,555						1,079,555
Warrant exercised				1,079,555		1,079,555						1,079,555
Sales Agreement [Member] \| Maximum [Member] \| Alliance Global Partners [Member] \| ATM Offering [Member]
OrganizationLineItems [Line Items]
Maximum value to be sold at the market offering			$ 2,400,000